Search Results - "OMACHI, NAOKI"

Spinal Cord Infarction after Bronchial Artery Embolization for Hemoptysis: A Nationwide Observational Study in Japan by Ishikawa, Hideo, Ohbe, Hiroyuki, Omachi, Naoki, Morita, Kojiro, Yasunaga, Hideo

“…Background The most serious complication of bronchial artery embolization (BAE) for hemoptysis is spinal cord infarction. However, because it is rare, previous…”
Get full text

Mechanisms of recurrent haemoptysis after super-selective bronchial artery coil embolisation: a single-centre retrospective observational study by Ryuge, Misaki, Hara, Masahiko, Hiroe, Takanori, Omachi, Naoki, Minomo, Shojiro, Kitaguchi, Kazushi, Youmoto, Mihoko, Asakura, Norihiro, Sakata, Yasushi, Ishikawa, Hideo

“…Objectives In recognition of the significant impairment caused by haemoptysis on a patient’s quality of life, bronchial artery embolisation has been introduced…”
Get full text

Bronchial Artery Aneurysm: Prevalence, Clinical Characteristics, and Long-Term Prognosis Following Bronchial Artery Embolization by Omachi, Naoki, Ishikawa, Hideo, Nishihara, Takashi, Yamaguchi, Yu, Kitaoka, Aya, Kitaguchi, Kazushi, Hattori, Tomoaki, Kawaguchi, Tomoya

“…To investigate the prevalence, clinical characteristics, and long-term prognosis of bronchial artery aneurysm (BAA) following bronchial artery embolization…”
Get full text

The impact of bronchial artery embolisation on the quality of life of patients with haemoptysis: a prospective observational study by Omachi, Naoki, Ishikawa, Hideo, Hara, Masahiko, Nishihara, Takashi, Yamaguchi, Yu, Yamamoto, Yumiko, Youmoto, Mihoko, Hattori, Tomoaki, Kitaguchi, Kazushi, Yamamoto, Shota, Kawaguchi, Tomoya, Fukuzawa, Masahiro

“…Objectives Patients with haemoptysis often experience daily physical and mental impairment. Bronchial artery embolisation is among the first-line treatment…”
Get full text

Erratic coil migration in the bronchus after bronchial artery embolization by Ishikawa, Hideo, Omachi, Naoki, Ryuge, Misaki, Takafuji, Jun, Hara, Masahiko

“…Herein, we report two cases of erratic coil migration from the bronchial artery to the bronchus after bronchial artery embolization (BAE). Neither patient…”
Get full text

Life-threatening and Rapidly Growing Teratoma in the Anterior Mediastinum by Omachi, Naoki, Kawaguchi, Tomoya, Shimizu, Shigeki, Okuma, Tomohisa, Kitaichi, Masanori, Atagi, Shinji, Yoon, Hyung-Eun, Matsumura, Akihide

“…This report describes the case of a 23-year-old man with a mediastinal teratoma. Five months before admission, a chest radiograph during a routine health…”
Get full text

Successful bronchial artery embolization using hydrogel coils for hemoptysis during extracorporeal membrane oxygenation by Nishihara, Takashi, Okamoto, Yutaro, Ishikawa, Hideo, Omachi, Naoki, Yoshikawa, Yoshiaki, Ishida, Kenichiro, Toratani, Masayasu, Ohnishi, Mitsuo

“…A 58-year-old woman with bronchiectasis presented with massive hemoptysis and severe respiratory failure, which required long-term extracorporeal membrane…”
Get full text

Duration of twice-daily thoracic radiotherapy and time from the start of any treatment to the end of chest irradiation as significant predictors of outcomes in limited-disease small-cell lung cancer by Morimoto, Masahiro, Okishio, Kyoichi, Akira, Masanori, Omachi, Naoki, Tamiya, Akihiro, Asami, Kazuhiro, Kawaguchi, Tomoya, Atagi, Shinji

“…Abstract Backgrounds The hypothesis of this retrospective study was that the duration of twice-daily (BID) thoracic radiotherapy (TRT) and time from the start…”
Get full text

Combination of virtual bronchoscopic navigation, endobronchial ultrasound, and rapid on-site evaluation for diagnosing small peripheral pulmonary lesions: a prospective phase II study by Maekura, Toshiya, Sugimoto, Chikatoshi, Tamiya, Akihiro, Saijo, Nobuhiko, Naoki, Yoko, Koba, Taro, Kimura, Yohei, Matsuda, Yoshinobu, Kanazu, Masaki, Takeuchi, Naoko, Sasaki, Yumiko, Naito, Yujiro, Tsuji, Taisuke, Sugawara, Reiko, Kobayashi, Takehiko, Nakao, Keiko, Taniguchi, Yoshihiko, Okishio, Kyoichi, Omachi, Naoki, Kasai, Takahiko, Atagi, Shinji

“…The diagnostic yield of peripheral pulmonary lesions (PPLs) by flexible bronchoscopy (FB) is still insufficient. To improve the diagnostic yield of…”
Get full text

Prevalence of non-bronchial systemic culprit arteries in patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization by Nishihara, Takashi, Ishikawa, Hideo, Omachi, Naoki, Yamaguchi, Yu, Kitaguchi, Kazushi, Hattori, Tomoaki

“…Objectives To identify the prevalence of non-bronchial systemic culprit arteries and their relationship to bleeding lobes in patients with hemoptysis with…”
Get full text

Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study by Tamiya, Akihiro, Tamiya, Motohiro, Nishihara, Takashi, Shiroyama, Takayuki, Nakao, Keiko, Tsuji, Taisuke, Takeuchi, Naoko, Isa, Shun-Ichi, Omachi, Naoki, Okamoto, Norio, Suzuki, Hidekazu, Okishio, Kyoichi, Iwazaki, Ayano, Imai, Kimie, Hirashima, Tomonori, Atagi, Shinji

“…Afatinib is an effective first-line treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC)…”
Get full text

A case of large-cell neuroendocrine carcinoma harboring an EML4-ALK rearrangement with resistance to the ALK inhibitor crizotinib by Omachi, Naoki, Shimizu, Shigeki, Kawaguchi, Tomoya, Tezuka, Kenji, Kanazu, Masaki, Tamiya, Akihiro, Asami, Kazuhiro, Okishio, Kyoichi, Kitaichi, Masanori, Atagi, Shinji

Get more information

Epidermal growth factor receptor tyrosine kinase inhibitors beyond progressive disease: a retrospective analysis for Japanese patients with activating EGFR mutations by Nishie, Kenichi, Kawaguchi, Tomoya, Tamiya, Akihiro, Mimori, Tomoyasu, Takeuchi, Naoko, Matsuda, Yoshinobu, Omachi, Naoki, Asami, Kazuhiro, Okishio, Kyoichi, Atagi, Shinji, Okuma, Tomohisa, Kubo, Akihito, Maruyama, Yoshihito, Kudoh, Shinzoh, Takada, Minoru

“…It is not determined whether the continuous use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) is reasonable for patients with…”
Get more information

Impact of metastatic status on the prognosis of EGFR mutation-positive non-small cell lung cancer patients treated with first-generation EGFR-tyrosine kinase inhibitors by Taniguchi, Yoshihiko, Tamiya, Akihiro, Nakahama, Kenji, Naoki, Yoko, Kanazu, Masaki, Omachi, Naoki, Okishio, Kyoichi, Kasai, Takahiko, Atagi, Shinji

“…The aim of the present study was to analyze the impact of metastatic status on the prognosis of epithelial growth factor receptor (EGFR) mutation-positive…”
Get full text

Continued treatment with gefitinib beyond progressive disease benefits patients with activating EGFR mutations by Asami, Kazuhiro, Okuma, Tomohisa, Hirashima, Tomonori, Kawahara, Masaaki, Atagi, Shinji, Kawaguchi, Tomoya, Okishio, Kyoichi, Omachi, Naoki, Takeuchi, Naoko

“…Abstract Background Gefitinib is an effective treatment for patients with non-small cell lung cancer who harbor activating epidermal growth factor receptor…”
Get full text

Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysis by Naito, Yujiro, Tamiya, Akihiro, Tamiya, Motohiro, Kimura, Yohei, Hamaguchi, Masanari, Saijo, Nobuhiko, Kanazu, Masaki, Tokura, Sayoko, Shiroyama, Takayuki, Morisita, Naoko, Omachi, Naoki, Suzuki, Hidekazu, Okamoto, Norio, Okishio, Kyoichi, Hirashima, Tomonori, Atagi, Shinji

“…Although small cell lung cancer (SCLC) is initially sensitive to chemotherapy, it recurs in most cases. Standard regimens for salvage chemotherapy have not…”
Get full text

Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion by Tamiya, Motohiro, Tamiya, Akihiro, Yasue, Tomomi, Nakao, Keiko, Omachi, Naoki, Shiroyama, Takayuki, Tani, Eriko, Hamaguchi, Masanari, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Okishio, Kyoichi, Kawaguchi, Tomoya, Atagi, Shinji, Hirashima, Tomonori

“…Malignant effusion is associated with high serum and plasma levels of vascular endothelial growth factor (VEGF). There are no biomarkers of outcome for…”
Get full text

Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations by Tamiya, Motohiro, Tamiya, Akihiro, Shiroyama, Takayuki, Takeoka, Sawa, Naito, Yujiro, Omachi, Naoki, Kimura, Yohei, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Okishio, Kyoichi, Kawaguchi, Tomoya, Atagi, Shinji, Hirashima, Tomonori

“…Summary Background Cisplatin and pemetrexed are very effective against advanced non-squamous non-small cell lung cancer (NSCLC) without EGFR mutations…”
Get full text

Fast-track cardiac anesthesia and perioperative management appropriate for early rehabilitation after coronary artery bypass graft (CABG) surgery by Watanabe, Yasuhiko, Kosaka, Makoto, Kusume, Yoshio, Suga, Taro, Hatakenaka, Toyohito, Omachi, Naoki, Irie, Hiroyuki, Morita, Terumasa

“…Rapid mobilization and rehabilitation after CABG has a potential benefit of reducing both costs and pulmonary complications (such as atelectasis and pulmonary…”
Get more information

Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations by Tamiya, Akihiro, Tamiya, Motohiro, Shiroyama, Takayuki, Saijo, Nobuhiko, Nakatani, Takeshi, Minomo, Shojiro, Tsuji, Taisuke, Takeuchi, Naoko, Omachi, Naoki, Kurata, Kanako, Suzuki, Hidekazu, Okamoto, Norio, Okishio, Kyoichi, Hirashima, Tomonori, Atagi, Shinji

“…Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is an effective treatment for advanced non-small cell lung cancer (NSCLC)…”
Get full text